In the last few months, Artificial Intelligence started to become a big thing within many areas, e.g. the creative industry. There are AI generated pictures, Videos, Music. 

But how can AI’s be used in a medical environment? 

The company Verisim Life has an idea for that: 

Their new AI program Bioisim is built to de-risk decision making within R&D Translation and with that lowers the use of animal testing and the longevity and risks of clinical testing. 

“This white paper showcases how fusing artificial intelligence and mechanistic modeling can be used to accurately predict the disposition of small molecules across different subjects for translation to clinical success.” (Verism Life Website)